MMP2 and breast carcinoma: MMP-2, in turn, is responsible for generating collagen IV peptides as a byproduct of proteolytic activity—fragments with chemo-attractive properties for bone-marrow-derived cells and future metastatic breast cancer cells recruited to the pre-metastatic niche [58].